Radiomics in esophageal and gastric cancer

Bert-Ram Sah; Kasia Owczarczyk; Musib Siddique; Gary J.R. Cook; Vicky Goh

doi:10.1007/s00261-018-1724-8

Radiomics in esophageal and gastric cancer

Bert-Ram Sah, Kasia Owczarczyk, Musib Siddique, Gary J.R. Cook, Vicky Goh^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

62 Citations (Scopus)

Abstract

Esophageal, esophago-gastric, and gastric cancers are major causes of cancer morbidity and cancer death. For patients with potentially resectable disease, multi-modality treatment is recommended as it provides the best chance of survival. However, quality of life may be adversely affected by therapy, and with a wide variation in outcome despite multi-modality therapy, there is a clear need to improve patient stratification. Radiomic approaches provide an opportunity to improve tumor phenotyping. In this review we assess the evidence to date and discuss how these approaches could improve outcome in esophageal, esophago-gastric, and gastric cancer.

Original language	English
Journal	Abdominal Radiology
Early online date	16 Aug 2018
DOIs	https://doi.org/10.1007/s00261-018-1724-8
Publication status	E-pub ahead of print - 16 Aug 2018

Keywords

Computed tomography
Esophageal cancer
Esophagogastric junction cancer
Magnetic resonance imaging
Positron emission tomography
Radiomics

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00261-018-1724-8Licence: CC BY

Cite this

@article{bd102bccf3714be4ac645f4ca76767f4,

title = "Radiomics in esophageal and gastric cancer",

abstract = "Esophageal, esophago-gastric, and gastric cancers are major causes of cancer morbidity and cancer death. For patients with potentially resectable disease, multi-modality treatment is recommended as it provides the best chance of survival. However, quality of life may be adversely affected by therapy, and with a wide variation in outcome despite multi-modality therapy, there is a clear need to improve patient stratification. Radiomic approaches provide an opportunity to improve tumor phenotyping. In this review we assess the evidence to date and discuss how these approaches could improve outcome in esophageal, esophago-gastric, and gastric cancer.",

keywords = "Computed tomography, Esophageal cancer, Esophagogastric junction cancer, Magnetic resonance imaging, Positron emission tomography, Radiomics",

author = "Bert-Ram Sah and Kasia Owczarczyk and Musib Siddique and Cook, {Gary J.R.} and Vicky Goh",

year = "2018",

month = aug,

day = "16",

doi = "10.1007/s00261-018-1724-8",

language = "English",

journal = "Abdominal Radiology",

issn = "2366-004X",

publisher = "Springer New York",

}

TY - JOUR

T1 - Radiomics in esophageal and gastric cancer

AU - Sah, Bert-Ram

AU - Owczarczyk, Kasia

AU - Siddique, Musib

AU - Cook, Gary J.R.

AU - Goh, Vicky

PY - 2018/8/16

Y1 - 2018/8/16

N2 - Esophageal, esophago-gastric, and gastric cancers are major causes of cancer morbidity and cancer death. For patients with potentially resectable disease, multi-modality treatment is recommended as it provides the best chance of survival. However, quality of life may be adversely affected by therapy, and with a wide variation in outcome despite multi-modality therapy, there is a clear need to improve patient stratification. Radiomic approaches provide an opportunity to improve tumor phenotyping. In this review we assess the evidence to date and discuss how these approaches could improve outcome in esophageal, esophago-gastric, and gastric cancer.

AB - Esophageal, esophago-gastric, and gastric cancers are major causes of cancer morbidity and cancer death. For patients with potentially resectable disease, multi-modality treatment is recommended as it provides the best chance of survival. However, quality of life may be adversely affected by therapy, and with a wide variation in outcome despite multi-modality therapy, there is a clear need to improve patient stratification. Radiomic approaches provide an opportunity to improve tumor phenotyping. In this review we assess the evidence to date and discuss how these approaches could improve outcome in esophageal, esophago-gastric, and gastric cancer.

KW - Computed tomography

KW - Esophageal cancer

KW - Esophagogastric junction cancer

KW - Magnetic resonance imaging

KW - Positron emission tomography

KW - Radiomics

UR - http://www.scopus.com/inward/record.url?scp=85052106910&partnerID=8YFLogxK

U2 - 10.1007/s00261-018-1724-8

DO - 10.1007/s00261-018-1724-8

M3 - Article

AN - SCOPUS:85052106910

SN - 2366-004X

JO - Abdominal Radiology

JF - Abdominal Radiology

ER -

Radiomics in esophageal and gastric cancer

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this